Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
3.790
-0.300 (-7.33%)
At close: Jul 23, 2026, 4:00 PM EDT
3.790
0.00 (0.00%)
After-hours: Jul 23, 2026, 4:00 PM EDT

UPC Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
17.8623.0232.3140.1447.98
Revenue Growth (YoY)
-22.44%-28.74%-19.52%-16.34%56.27%
Cost of Revenue
11.5616.9521.9918.2522.66
Gross Profit
6.36.0710.3221.8925.33
Selling, General & Admin
8.5511.069.4221.276.27
Research & Development
0.673.034.867.645.47
Total Operating Expenses
9.2214.0914.2828.9111.74
Operating Income
-2.92-8.02-3.97-7.0213.59
Interest Income
0.070.030.030.040.27
Interest Expense
-0.23-0.28-0.16-0.16-0.1
Other Non-Operating Income (Expense)
-0.590.15-0.240.05-0.08
Total Non-Operating Income (Expense)
-0.76-0.1-0.36-0.070.09
Pretax Income
-3.67-8.12-4.33-7.0913.68
Provision for Income Taxes
--0.61-2.25-0.82-2.36
Net Income
-3.67-7.51-2.07-6.2816.04
Net Income to Common
-3.67-8.73-6.58-7.9111.32
Net Income Growth
----49.77%
Shares Outstanding (Basic)
00000
Shares Outstanding (Diluted)
00000
Shares Change (YoY)
3174.93%130.39%-14.59%18.63%
EPS (Basic)
-8.06-626.96-1089.21-1309.112147.99
EPS (Diluted)
-8.06-626.96-1089.21-1309.112147.99
EPS Growth
----26.95%
Free Cash Flow
-5.32-9.751.07-1.39-15.59
Free Cash Flow Per Share
-11.67-700.61177.53-230.84-2956.31
Gross Margin
35.28%26.37%31.93%54.53%52.78%
Operating Margin
-16.33%-34.83%-12.28%-17.49%28.32%
Profit Margin
-20.56%-32.63%-6.42%-15.64%33.42%
FCF Margin
-29.78%-42.36%3.32%-3.47%-32.49%
EBITDA
-2.4-7.53-3.46-6.4914.04
EBITDA Margin
-13.43%-32.72%-10.70%-16.16%29.25%
EBIT
-2.92-8.02-3.97-7.0213.59
EBIT Margin
-16.33%-34.83%-12.28%-17.49%28.32%
Effective Tax Rate
0.00%7.47%52.08%11.49%-17.24%
SEC Filings: 10-K · 10-Q